Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 4/20 | 0.33 |
| ▸ | MAOA | P21397 | 3/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 5/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14962002 | 0.89 | SIGMAR1 (0.36) | MAOBMAOASIGMAR1ALDH1A1HPGD | |
| SCHEMBL14961999 | 0.87 | ALDH1A1 (0.34) | ADORA3ADORA2AADORA1MAOBMAOA | |
| SCHEMBL14962003 | 0.83 | — | — | |
| SCHEMBL14962008 | 0.78 | SIGMAR1 (0.33) | SIGMAR1 | |
| SCHEMBL21939994 | 0.73 | SIGMAR1 (0.39) | MAOASIGMAR1ALDH1A1CYP2A6HPGD | |
| SCHEMBL17933025 | 0.71 | CYP2A6 (0.50) | SIGMAR1ALDH1A1CYP2A6HPGDTSHR | |
| SCHEMBL8204842 | 0.71 | SIGMAR1 (0.44) | SIGMAR1ALDH1A1CYP2A6TSHRKDM4E | |
| SCHEMBL15852464 | 0.70 | MAOA (0.34) | ADORA3ADORA2AADORA1MAOBMAOA | |
| SCHEMBL14962006 | 0.70 | CYP2D6 (0.32) | — | |
| SCHEMBL14962028 | 0.70 | KMT2A (0.36) | MAOBMAOACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11563178-B2 | Organic electroluminescent element, compound for use in the element, and light emitting device, display device, and illumination device using the element | UDC IRELAND LIMITED (IE) | 2023-01-24 | — | — | US | disclosed |
| US-20180069179-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | UDC IRELAND LTD (IE) | 2018-03-08 | — | — | US | disclosed |
| US-20180069179-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | UDC IRELAND LTD (IE) | 2018-03-08 | — | — | US | disclosed |
| US-20130126835-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | UDC IRELAND LIMITED (IE) | 2013-05-23 | — | — | US | disclosed |
| US-20130126835-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | UDC IRELAND LIMITED (IE) | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180069179-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | L1CAM, RER1, H1-0 | ADORA3 2608/4885ADORA2A 2816/4885ADORA1 1145/4885 |
| US-11563178-B2 | Organic electroluminescent element, compound for use in the element, and light emitting device, display device, and illumination device using the element | L1CAM, RER1, H1-0 | ADORA3 2608/4885ADORA2A 2816/4885ADORA1 1145/4885 |
| US-20130126835-A1 | Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element | L1CAM, RER1, H1-0 | ADORA3 2608/4885ADORA2A 2816/4885ADORA1 1145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.